Status:
UNKNOWN
Deep Brain Stimulation in Forel's H Field in Tourette's Syndrome
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Tourette Syndrome
Eligibility:
All Genders
14-100 years
Phase:
NA
Brief Summary
Tourette's Syndrome (TS) is a neurodevelopmental disease characterized tics that start before the age of 18 years. About 5% of cases do not respond to drug treatment and can be classified as refractor...
Detailed Description
Sixteen patients with TS will be included in our protocol. The tics must have a negative influence in the quality of life of these patients. Patients will be submitted to a neuronavigation protocol fo...
Eligibility Criteria
Inclusion
- Patients with Tourette's Syndrome diagnosis.
- Age equal to or above 14 years.
- Severe impairment of motor tics (Yale Global Tic Severity Scale ≥ 35/50).
- Patients who are refractory to drug treatment.
- Patients intellectually able to understand and sign the consent form.
- Possibility to adhere to research and periodic medical visits after surgery.
Exclusion
- Inability to consent to your participation in the study.
- Patients with non-stabilized psychiatric comorbidities, such as anxiety and depression.
- Concomitant treatment with other experimental drugs.
- Women who are pregnant or breastfeeding.
- Patients undergoing previous neurosurgical procedures for the treatment of Tourette's Syndrome.
Key Trial Info
Start Date :
February 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 27 2023
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04342754
Start Date
February 27 2019
End Date
June 27 2023
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of São Paulo
São Paulo, São Paulo, Brazil, 05403-000